英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Overtopped查看　Overtopped　在百度字典中的解释百度英翻中〔查看〕
Overtopped查看　Overtopped　在Google字典中的解释Google英翻中〔查看〕
Overtopped查看　Overtopped　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Adstiladrin: Uses, Dosage, Side Effects Warnings - Drugs. com
    Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus CalmetteGuérin (BCG)-unresponsive non-muscle invasive bladder cancer Includes Adstiladrin side effects, interactions and indications
  • ADSTILADRIN | FDA
    For the treatment of High-grade, Bacillus Calmette-Guerin (BCG) unresponsive non-muscle invasive bladder cancer
  • ADSTILADRIN® (nadofaragene firadenovec-vncg) | For HCP
    Nadofaragene firadenovec- vncg (ADSTILADRIN) is A recommended treatment option: In the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)* and the AUA SUO Guidelines1 By the International Bladder Cancer Group (IBCG) for high-risk NMIBC after BCG failure for those seeking to avoid radical cystectomy 2
  • Ferring Adds Three New Studies to Non-Muscle Invasive Bladder . . .
    ADSTILADRIN ® (nadofaragene firadenovec-vncg) is the first and only FDA-approved intravesical non-replicating gene-therapy for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors
  • ADSTILADRIN® (nadofaragene firadenovec-vncg) | NMIBC Treatment
    STIL EFFECTIVE out to 5 years In a clinical study, ADSTILADRIN was tested in people with high-risk NMIBC whose cancer did not respond to BCG They had checkups over 5 years to measure how well treatment helped them keep their bladder, avoid progressing to MIBC, and remain free of high-grade bladder cancer signs
  • Nadofaragene firadenovec-vncg (urinary bladder route)
    Description Nadofaragene Firadenovec-vncg is used to treat patients with high-risk Bacillus Calmette-Guerin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) with a tumor type called carcinoma in situ (CIS) with or without papillary tumors This medicine is to be used only by or under the direct supervision of a doctor
  • Interferon gene therapy with nadofaragene firadenovec for . . .
    Abstract Bladder cancer is a prevalent malignancy with limited therapeutic options, particularly for patients who are unresponsive to Bacillus Calmette-Guérin (BCG) The approval of interferon-α (IFNα) gene therapy with nadofaragene firadenovec (Adstiladrin ®), the first gene therapy for genitourinary malignancies, has provided a promising alternative This article reviews the research and
  • ADSTILADRIN® in Patients With High-Risk, BCG Unresponsive NMIBC
    The 2025 SESAUA annual meeting featured a bladder cancer session and a presentation by Dr Amy Luckenbaugh discussing the durability of nadofaragene firadenovec response in participants with BCG unresponsive non-muscle invasive disease Nadofaragene firadenovec is an intravesical gene therapy for BCG-unresponsive non–muscle invasive bladder cancer with CIS with without papillary tumors (±
  • Adstiladrin | European Medicines Agency (EMA)
    Nadofaragene firadenovec is a non-replicating, recombinant type 5 adenovirus vector-based gene therapy containing the human IFNα2b transgene Its intravesical administration results in the entry of viral particles into the tumour cells and the urothelium of the bladder, leading to the expression of the IFNα2b protein in such cells, which in
  • Nadofaragene Firadenovec-vncg - NCI - National Cancer Institute
    This page contains brief information about nadofaragene firadenovec-vncg and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials





中文字典-英文字典  2005-2009